₹41.5
■ +0 +0.00%
29 Jul 2026
BSE Listed
Clinitech Laboratory Limited (544220)
Volume: 0Avg Vol 1W: 2,640Avg Vol 1M: 2,45552W Range:₹28.55₹57
Key Ratios
Checked just nowMarket Cap—
Current Price₹41.5
Previous Close₹41.5
High / Low (52w)₹57 / ₹28.55
Volume0
Avg Vol (1W)2,640
Avg Vol (1M)2,455
Stock P/E—
Book Value—
Dividend Yield—
ROE—
ROA—
Revenue (TTM)—
Revenue Growth—
Profit Margin—
Total Debt—
Shares Outstanding—
Face Value—
EPS (TTM)—
P/B—
Debt / Equity0.07
50 DMA₹40.17
200 DMA₹45.09
Day change+0.00%
Price Chart
₹41.5▲ 33.87% · 1Y
2025-07-302026-07-29
20-day avg volume: 3K shares
Pros
- Company is almost debt-free.
- Revenue grew 31% YoY.
Profit & Loss (Annual)
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Revenue | ₹5 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹8 Cr |
| EBITDA | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| Net Profit | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr |
| EPS | 6.04 | 3.42 | 4.09 | 2.37 | 1.9 |
Balance Sheet
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Total Assets | ₹3 Cr | ₹4 Cr | ₹6 Cr | ₹6 Cr | ₹11 Cr |
| Total Liabilities | ₹1 Cr | ₹2 Cr | ₹4 Cr | ₹2 Cr | ₹2 Cr |
| Equity | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹4 Cr | ₹9 Cr |
| Total Debt | — | — | — | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Operating | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹-1 Cr | ₹-1 Cr |
| Investing | ₹1 Cr | ₹-1 Cr | ₹-1 Cr | ₹1 Cr | ₹-1 Cr |
| Financing | ₹-1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹4 Cr |
| Free Cash Flow | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹-1 Cr | ₹-1 Cr |
Shareholding
Promoter 64.2% Institutions 0.32% Public 35.48%
Efficiency & Working Capital
ROCE—
Interest Coverage9
Dividend Payout—
Debtor Days68 d
Inventory Days23 d
Payable Days28 d
Cash Conversion Cycle64 d
Working Capital Days92 d
Shareholding Details
As of 2026-03-31
Promoter64.2%
FII0.3%
DII0%
Institutions0.3%
Public35.5%
Promoter Pledge0%
No. of Shareholders297
Shareholding Pattern
Quarterly — figures in %. Latest 6 quarters.
| Period | Jan 2024 | Jul 2024 | Sept 2024 | Mar 2025 | Sept 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 83.6% | 61.6% | 61.6% | 61.6% | 62.4% | 64.2% |
| FIIs | 0% | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 16.4% | 38.1% | 38.1% | 38.1% | 37.3% | 35.5% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 24 | 450 | 346 | 303 | 303 | 297 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Jagdish Umakant Nayak | Shareholding of Promoter and Promoter Group | 31.7% | 7,22,500 |
| Jyoti Jagdish Nayak | Shareholding of Promoter and Promoter Group | 29.6% | 6,75,000 |
| Santosh Gopalkrishna Kudva | Public Shareholding | 5.8% | 1,33,200 |
| Krisha V Talreja | Public Shareholding | 3.1% | 70,800 |
| Siddhesh Anant Nayak | Shareholding of Promoter and Promoter Group | 2.4% | 55,500 |
| Ajit Sakharam Kandar | Public Shareholding | 2.2% | 51,200 |
| Shirish Nanubhai Patel | Public Shareholding | 1.6% | 36,000 |
| Siddhesh Nayak | Shareholding of Promoter and Promoter Group | 0.5% | 12,000 |
| Anant Umakant Nayak | Shareholding of Promoter and Promoter Group | 0% | 100 |
| Ashutosh Jagdish Nayak | Shareholding of Promoter and Promoter Group | 0% | 100 |
| Eshwari Anant Nayak | Shareholding of Promoter and Promoter Group | 0% | 100 |
| Ananya Jagdish Nayak | Shareholding of Promoter and Promoter Group | 0% | 100 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Jagdish Umakant Nayak | Chairman & Managing Director | 2025 |
| Jyoti Jagdish Nayak | Whole-time Director | 2025 |
| Ashutosh Jagdish Nayak | Non-Exec & Non-Independent Dir | 2025 |
| Balu Laxman Kumbharkar | Independent Non Exe. Director | 2025 |
| Smita Arjun Patil | Independent Non Exe. Director | 2025 |
| Ravikant Moreshwar Mhatre | Independent Non Exe. Director | 2025 |
| Shruti Hemant Patankar | Company Sec. & Compli. Officer | 2025 |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 5 | 2 | 2 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 1 | 0 | 1 |
| 2025 | 0 | 0 | 0 | 1 | 0 | 1 |
| 2025 | 0 | 0 | 0 | 1 | 0 | 1 |
Insider / Designated-Person Trades
12 recent disclosure(s)
Mr. Jagdish Umakant NayakAcquisition · 9,600
Mr. Siddhesh Anant NayakAcquisition · 1,200
Mr. Jagdish Umakant NayakAcquisition · 1,200
Mr. Siddhesh Anant NayakAcquisition · 2,400
JAGDISH UMAKANT NAYAKAcquisition · 4,800
JAGDISH UMAKANT NAYAKAcquisition · 4,800
Substantial Acquisitions (SAST)
6 disclosure(s)
Market30/03/2026 · 9,600
Market25/03/2026 · 1,200
Market24/03/2026 · 2,400
Market19/03/2026 - 20/03/2026 · 4,800
Market17/03/2026 - 18/03/2026 · 4,800
Market26/09/2025 · 8,400
Company Information
🌐 www.ctllab.in ↗
📍 AL-1/545 Sector 16 Airoli, Opp Radhikabai Megha Vidyalaya, Navi Mumbai, Maharashtra, 400708
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search